SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXYS Pharmaceuticals Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: schadenfreude who wrote (48)3/7/1998 12:42:00 PM
From: Steve Lokness  Read Replies (1) of 455
 
Otaku;

Axys is mentioned in the Feb 21st-Feb27th issue of The Economist in a very extensive article on the evolution of the drug industry. The mention of Axys is in reference to "pharmacogenics" and how both time and money can be saved getting new drugs approved. I would suggest that anyone interested and investing in biotechnology get a copy of this article.

Did the pharmacogenics work come from SQNA? As one who is now a AXPH holder from SQNA, I remain convinced that Walker knows what he is doing and will bring shareholder value to this company. If this perception spreads this might be a better time to get into this stock than a year from now.

Good Luck.
Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News